Furthermore, our research implied that RHBDF2 upregulation was significantly linked to immune cell infiltration and revealed a potential molecular mechanism by which that RHBDF2 can impact the prognosis of HCC patients partly because of tumor immune infiltration. Here, RHBDF2 is linked to hepatocellular carcinoma.